Improved pharmacokinetic and biodistribution properties of the selective urokinase inhibitor PAI-2 (SerpinB2) by site-specific PEGylation: implications for drug delivery.
about
Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy.The Continuous Concentration of Particles and Cancer Cell Line Using Cell Margination in a Groove-Based Channel
P2860
Improved pharmacokinetic and biodistribution properties of the selective urokinase inhibitor PAI-2 (SerpinB2) by site-specific PEGylation: implications for drug delivery.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Improved pharmacokinetic and b ...... mplications for drug delivery.
@en
type
label
Improved pharmacokinetic and b ...... mplications for drug delivery.
@en
prefLabel
Improved pharmacokinetic and b ...... mplications for drug delivery.
@en
P2093
P2860
P1476
Improved pharmacokinetic and b ...... implications for drug delivery
@en
P2093
Kara Lea Vine
Nathanial Lachlan Ewart Harris
Sergei Lobov
P2860
P304
P356
10.1007/S11095-014-1517-X
P577
2014-09-18T00:00:00Z